Eli Lilly has presented early positive clinical data supporting once-weekly dosing for its GIP/GLP-1 receptor agonist candidate brenipatide in substance use, psychiatric, and immunologic disorders—and ...

In his new book "Curved Air", Kevin Davies, PhD, portrays the fascinating story of sickle cell disease, from its origins in ...

A new genome-editing method, prime assembly, precisely inserts long DNA sequences into targeted genomic locations.

Del-desiran was one of three clinical setbacks for Novartis within a week. On 4, Novartis and Ionis Pharmaceuticals ...

Study identified age-related HGG patient groups that demonstrated distinct molecular profiles and survival outcomes, and were ...

Findings provide some of the strongest human evidence to date that expansion of the Huntington mutation is a key factor in ...

A majority of biopharmas are expected to increase their reliance on CDMOs in coming years despite rising costs for their ...

Researchers at Virginia Tech have developed a prophylactic phage therapy approach to protecting against potential future ...

A new microprotein atlas of the human frontal cortex reveals more than 1,000 previously uncharacterized microproteins.

Discovery could open up new avenues for studying diseases that affect the brainstem, such as spinal muscular atrophy and amyotrophic lateral sclerosis.